New study aims to measure how CLN2 affects Kids' skills over time
NCT ID NCT03862274
First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 24 times
Summary
This study follows 30 children with CLN2 Batten disease to measure changes in thinking, movement, and language skills over time. Researchers will compare children who receive the treatment cerliponase alfa with those who do not. The goal is to find better ways to track the disease and improve standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BATTEN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Conditions
Explore the condition pages connected to this study.